- Home
- CMPS vs SFST Comparison
CMPS vs SFST Comparison
Compare CMPS & SFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- SFST
- Stock Information
- Founded
- CMPS 2020
- SFST 1999
- Country
- CMPS United Kingdom
- SFST United States
- Employees
- CMPS N/A
- SFST N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- SFST Major Banks
- Sector
- CMPS Health Care
- SFST Finance
- Exchange
- CMPS Nasdaq
- SFST Nasdaq
- Market Cap
- CMPS 364.9M
- SFST 335.4M
- IPO Year
- CMPS 2020
- SFST 1999
- Fundamental
- Price
- CMPS $4.61
- SFST $44.94
- Analyst Decision
- CMPS Strong Buy
- SFST Buy
- Analyst Count
- CMPS 7
- SFST 1
- Target Price
- CMPS $17.00
- SFST $51.00
- AVG Volume (30 Days)
- CMPS 1.8M
- SFST 24.9K
- Earning Date
- CMPS 07-31-2025
- SFST 10-21-2025
- Dividend Yield
- CMPS N/A
- SFST N/A
- EPS Growth
- CMPS N/A
- SFST 58.48
- EPS
- CMPS N/A
- SFST 2.69
- Revenue
- CMPS N/A
- SFST $102,878,000.00
- Revenue This Year
- CMPS N/A
- SFST $6.08
- Revenue Next Year
- CMPS N/A
- SFST $13.23
- P/E Ratio
- CMPS N/A
- SFST $16.62
- Revenue Growth
- CMPS N/A
- SFST 15.60
- 52 Week Low
- CMPS $2.25
- SFST $29.14
- 52 Week High
- CMPS $8.54
- SFST $45.99
- Technical
- Relative Strength Index (RSI)
- CMPS 60.45
- SFST 67.24
- Support Level
- CMPS $3.97
- SFST $41.10
- Resistance Level
- CMPS $4.42
- SFST $42.40
- Average True Range (ATR)
- CMPS 0.22
- SFST 1.12
- MACD
- CMPS -0.01
- SFST 0.11
- Stochastic Oscillator
- CMPS 91.43
- SFST 98.89
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About SFST Southern First Bancshares Inc.
Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.